[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Bayer Animal Healths Veraflox for the purpose of patent e...[ Price : $8.95]
Justice Department official says the days of a money-only penalty in corporate criminal settlements is long over and company offic...[ Price : $8.95]
Public Citizen says its analysis of FDA records shows many reports of INRatio injuries and malfunctions in patients before a clini...[ Price : $8.95]
FDA accepts for priority review a Pfizer supplemental NDA for its breast cancer medication, Ibrance (palbociclib) for an expanded ...[ Price : $8.95]
An FDA-funded study demonstrates that consumers gain a better understanding of drug safety risk communications when they follow pl...[ Price : $8.95]
FDA staffers describe the process the agency followed in first rejecting and then approving Sprouts flibanserin for treating femal...[ Price : $8.95]
CDRH Office of Compliance (OC) acting director Sean Boyd says OC has several initiatives under way to shift the way it monitors or...[ Price : $8.95]
An online study sets the rate of leiomyosarcoma among women undergoing morcellation at 1 of 429 per 1,000 hysterectomies, riskier ...